{
  "nctId": "NCT01703598",
  "briefTitle": "Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis",
  "officialTitle": "Clinical Outcomes of Deep Brain Stimulator Electrodes Placed Using Intraoperative Computed Tomography and Frameless Stereotaxis Versus Microelectrode Recording and Frame-based Stereotaxis",
  "protocolDocument": {
    "nctId": "NCT01703598",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-10-06",
    "uploadDate": "2019-07-22T12:52",
    "size": 254811,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT01703598/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 69,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2011-09",
    "completionDate": "2017-03",
    "primaryCompletionDate": "2017-03",
    "firstSubmitDate": "2011-09-09",
    "firstPostDate": "2012-10-10"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Idiopathic Parkinson's disease patients identified by OHSU movement disorders neurologists as deep brain stimulation surgical candidates\n\nExclusion Criteria:\n\n* Subjects who have already undergone implantation of DBS electrodes 2.Age \\< - - 18 years\n* Surgical target site other than subthalamic nucleus or globus pallidus pars interna\n* Subjects who choose to undergo MER and frame-based stereotaxis for the placement of electrodes.\n* Patients who will receive follow up neurology care and DBS programming at centers other than OHSU.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Motor OFF Ldopa UPDRS",
        "description": "Change in motor UPDRS in OFF Levodopa state. The range of this outcome is from 0 to 108, a higher number indicated a worse clinical state.\n\nThe number represents units on this scale.",
        "timeFrame": "Baseline and 6 months"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 14,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:45.199Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}